Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 and Cardiovascular Diseases Publisher Pubmed



Geraiely B1 ; Samiei N2 ; Sadeghipour P3 ; Talasaz AH4 ; Mortazavi SH4 ; Sattarzadeh Badkoubeh R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Heart Valve Disease Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Advances in Experimental Medicine and Biology Published:2021


Abstract

We herein seek to expound on up-to-the-minute information regarding cardiovascular disease in the era of coronavirus disease 2019 (COVID-19) by highlighting acute myocardial injury caused by COVID-19 and probing into its pathophysiology, clinical signs, diagnostic tests, and treatment modalities. We aim to share the latest research findings vis-a-vis cardiovascular disease patients with confirmed or suspected COVID-19 on the association between hypertension and this infectious disease along with the relevant recommendations; describe the mechanism of coronary artery disease in such patients together with the necessary measures in the setting of non-ST-segment elevation acute coronary syndrome, ST-segment elevation myocardial infarction, and chronic coronary syndrome; discuss tachy- and bradyarrhythmias in the COVID-19 setting alongside their treatments; elucidate coagulopathies, venous thromboembolism, and its prophylactic measures in the context of this infection; set out the cardiopulmonary resuscitation protocol as well as the pertinent safety concerns during the current pandemic; and, finally, explicate drug-drug interactions between COVID-19 and cardiovascular medication in hypertension, acute coronary syndrome, heart failure, venous thromboembolism, and arrhythmias. © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
Other Related Docs
10. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
11. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
12. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
13. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
14. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
23. A Case of Multiple Large Left Ventricular Clots in a Patient With Covid-19, International Cardiovascular Research Journal (2021)
31. Covid-19 in Patients With Hypertension, Advances in Experimental Medicine and Biology (2021)
33. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
39. Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19, Seminars in Thrombosis and Hemostasis (2020)
43. Worldwide Survey of Covid-19-Associated Arrhythmias, Circulation: Arrhythmia and Electrophysiology (2021)